Interventional Oncology at Semmelweis University Receives International Recognition

Ma Reggel (“This Morning”) on the Hungarian television channel M1

Watch the news coverage highlighting the international recognition received by the Onco-Interventional Department at Semmelweis University. The segment features Dr. Pál Ákos Deák discussing the importance of IASIOS accreditation and what this milestone means for the advancement of high-quality interventional oncology care in Hungary and the region.

Semmelweis University Receives Landmark IASIOS Accreditation in Interventional Oncology

Hungary Today

Read the article on Semmelweis University becoming the first IASIOS Accredited Centre in Hungary and the Central and Eastern European region. The feature highlights how the accreditation recognises the university’s commitment to high-quality, minimally invasive cancer care and internationally aligned standards in interventional oncology. It also explores the growing role of interventional radiology in modern oncology treatment, education, and patient-centred care.

IASIOS announces first accredited centre in Canada

Interventional News

Read the press release announcing CHUM as the first IASIOS Accredited Centre in Canada. The release highlights the centre’s commitment to high-quality, patient-centred interventional oncology care and marks an important milestone for the advancement of IO services in Canada.

First Year Forward Grant 2026: Reflections from the inaugural recipients

Read the CIRSE Insider article featuring reflections from the inaugural recipients of the IASIOS First Year Forward Grant. Representatives from five centres share how the grant supported their accreditation journey, strengthened quality initiatives, and helped advance interventional oncology services within their institutions. Discover their experiences, insights, and advice for centres considering applying for the next round. 

Radiologia de Intervenção da ULS de Coimbra reconhecida como Centro Acreditado

The Interventional Radiology unit of ULS Coimbra has been officially recognised as an IASIOS Accredited Centre, underscoring its commitment to delivering high-quality interventional oncology services. The article outlines the rigorous standards met by the Medical Imaging team and includes insights from Paulo Donato, Director of the Medical Imaging Service, on the significance of this achievement. With only a limited number of centres worldwide holding IASIOS accreditation, ULS Coimbra’s recognition places it among a select group dedicated to standardised, safe, and efficient oncological care. The accomplishment also reinforces the institution’s role within the global IASIOS community, supporting continued quality improvement and collaboration in interventional oncology.

KSW awarded as the first Centre of Excellence for Interventional Oncology in Switzerland

The Cantonal Hospital Winterthur (KSW) has been recognised as Switzerland’s first IASIOS Centre of Excellence in Interventional Oncology. This highest level of international accreditation confirms compliance with both core and extended CIRSE quality assurance standards across the full patient pathway, from diagnosis to follow-up care. The award reflects structured multidisciplinary collaboration, advanced minimally invasive therapies, and internationally benchmarked quality processes.

Center for Interventional Oncology Earns IASIOS Accreditation

The NIH Clinical Center’s Center for Interventional Oncology has earned IASIOS accreditation, recognising strong standards in patient safety and quality across the full care pathway, from pre-procedure planning to post-procedure follow-up. Led by Cynthia Vasco, DNP, the 18-month process highlighted the centre’s multidisciplinary approach, outcome tracking, and safety metrics. IASIOS both validates current practice and signals a rising international benchmark alongside organisations such as the Joint Commission.
Read the full article to see how the NIH team achieved accreditation and what it means for patients and the field of interventional oncology.

Interventional Oncology: On the Forefront of Cancer Care and Innovation

RSNA News

The RSNA News article Interventional Oncology: On the Forefront of Cancer Care and Innovation highlights the growing importance of interventional oncology and emphasizes how the International Accreditation System for Interventional Oncology Services (IASIOS) is helping to set global standards for quality and safety. Since its launch in 2021, IASIOS has accredited more than 30 centres worldwide, with the Mallinckrodt Institute of Radiology becoming the first in the U.S. to achieve accreditation. By standardizing practice, improving safety protocols, and enhancing credibility with patients and physicians, IASIOS is raising the profile of interventional oncology and supporting its recognition as a key pillar of modern cancer care. Read the full article to learn more about how IASIOS is driving this progress.

Connecting centres, comparing practice: The role of benchmarking in interventional oncology

CIRSE Insider

The IASIOS Benchmarking Subcommittee, chaired by Prof. Miltiadis Krokidis, is advancing interventional oncology by fostering collaboration and data-driven improvement across centres. In this interview, Prof. Krokidis discusses the value of benchmarking for quality assurance, the subcommittee’s early initiatives, and its plans to expand data collection, workshops, and patient-focused measures. He also reflects on his personal motivation and offers guidance for centres considering IASIOS accreditation. Read the full article to learn how benchmarking is shaping continuous progress in interventional oncology.